Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway

Abstract excerpt

Meningiomas, which invade intracranial bone structures and the adjacent connective tissue, are frequently unresectable because of their aggressive and recalcitrant growth behavior. They have a high recurrence rate, and in approximately 10% of these tumors there is an increased risk of malignancy. Significant morbidity and mortality rates associated with recurrent meningiomas demand nonsurgical approaches. To...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Head and Neck Surgical Oncology
• Share to Meningioma and schwannoma management
• Share to Pituitary Gland Disorders and Treatments